Atorvastatin Calcium
Product Images NDC 43353-287
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 43353-287). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aphena Pharma Solutions (TN)
Figure-01 (Figure 01)
Figure-02 (Figure 02)
The text seems to be the data from a survival analysis study evaluating the effect of Atorvastatin on the hazard of experiencing a primary endpoint. The cumulative hazard of experiencing the event at different time points is provided along with the hazard ratio (HR) for Atorvastatin compared to the placebo. However, the rest of the information necessary to provide a comprehensive description is missing.*
Figure-03 (Figure 03)
This data presents the percentage of subjects who experienced "E vert" while taking different doses of Horvastatin and Sorvastatin. The study also reports a Hazard Ratio (HR) of 0.78, indicating a lower risk of developing major cardiovascular issues. The text seems to refer to a chart or graph displaying these statistics over time.*
Chemical-structure (Chemical Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.